Results 161 to 170 of about 37,448 (215)

Systemic scleroderma.

Minnesota medicine, 1966
openaire   +1 more source

Predictor factors of successful treatment response in interstitial lung disease-related systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Danasasmita GW, Wibowo SAK, Rumende CM, Rizka A, Sumariyono S, Ariane A, Shatri H, Singh G.   +7 more
europepmc   +1 more source

Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs. [PDF]

J Scleroderma Relat Disord
Mahmood M, Hughes M, McMahan Z, Shapiro L.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SYSTEMIC SCLEROSIS (SCLERODERMA)

Acta Clinica Belgica, 2007
Systemic sclerosis is a rare and often debilitating disorder characterized by a pathological triad: increased deposition of extracellular matrix and collagen in tissues, microvascular damage and dysfunction, and immune activation as evidenced by inflammation and frequent occurrence of autoantibodies.
Roufosse, Florence, Meric De Bellefon, Laurent   +1 more
openaire   +3 more sources

The fascia in systemic scleroderma

Journal of the American Academy of Dermatology, 1980
Diffuse fasciitis (DF) shares clinical and pathologic features with systemic (SS) and localized scleroderma. The distinct pathologic feature in DF is involvement of the deep fascia, but it is not known if these changes consistently occur in SS. In this study, ten patients with SS underwent deep biopsies for evaluation of the fascia.
M, Vázquez Botet, J L, Sánchez
openaire   +2 more sources

Systemic and localized scleroderma

Clinics in Dermatology, 2006
Sclerosing conditions of the skin are manifested by a full spectrum of presentations that includes skin-limited forms as well as those which can involve internal organs and result in death. At this point, we are just beginning to understand the mechanisms of tissue fibrosis, and it is likely that the fibrotic processes are a heterogeneous group of ...
Lorinda, Chung, Jan, Lin, Daniel E, Furst, David, Fiorentino   +3 more
openaire   +2 more sources

Localized and systemic scleroderma

Seminars in Cutaneous Medicine and Surgery, 2001
Scleroderma is a broad term encompassing both localized and systemic sclerosis. Localized scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized morphea, linear scleroderma, and deep morphea. Systemic scleroderma (sclerosis) can manifest as either limited or diffuse disease.
A, Hawk, J C, English
openaire   +2 more sources

Systemic Scleroderma

Medical Clinics of North America, 1989
Scleroderma encompasses a wide variety of diseases, including localized scleroderma, overlap syndromes, sclerodermoid conditions, and systemic scleroderma. This article emphasizes the systemic scleroderma.
openaire   +2 more sources

HLA in Systemic Scleroderma (PSS) and Familial Scleroderma

The Journal of Dermatology, 1991
AbstractHLA in systemic scleroderma (PSS), including three familial cases, is reported. Three families in which one sister developed PSS and another sister suffered from either PSS (family 1), mixed connective tissue disease (MCTD) (family 2), or Sjögren's syndrome (SjS) (family 3) were described.
T, Sasaki, K, Denpo, H, Ono, H, Nakajima
openaire   +2 more sources

Systemic Sclerosis, Scleroderma

2006
Abstract The scleroderma spectrum of disorders includes several diseases that have Raynaud’s phenomenon or skin sclerosis in common, comprising (1) localized cutaneous scleroderma; (2) systemic sclerosis (SSc)—the most important form of scleroderma—limited cutaneous SSc, diffuse cutaneous SSc, and overlap syndromes (with features of ...
Christopher P. Denton, Carol M. Black
openaire   +1 more source